Invasive tracheal mucormycosis complicated by myiasis following tracheostomy in a diabetic patient: A case report
Abstract
Invasive tracheal mucormycosis is a rare but fatal opportunistic infection, particularly common in immunocompromised patients. This case report describes a 23-year-old female diabetic patient who developed invasive tracheal mucormycosis following a tracheostomy. The mucormycosis infection was brought under control after antifungal therapy and surgical debridement; however, due to multiple contributing factors, the patient subsequently developed myiasis. This case highlights the importance of early diagnosis, aggressive treatment, and proper tracheostomy management in preventing severe complications.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.